Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models

Yong Luo, Abul Kalam Azad, Styliani Karanika, Spyridon P. Basourakos, Xuemei Zuo, Jianxiang Wang, Luan Yang, Guang Yang, Dimitrios Korentzelos, Jianhua Yin, Sanghee Park, Penglie Zhang, James J. Campbell, Thomas J. Schall, Guangwen Cao, Likun Li, Timothy C. Thompson

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models'. Together they form a unique fingerprint.

Medicine & Life Sciences